Scientific Advisory Board
Carlo M. Croce, MD
Dr. Croce is the John W. Wolfe Chair in Human Cancer Genetics, and Chairman, Department of Molecular Virology, Immunology and Medical Genetics at Ohio State University, and is also Director of the Human Cancer Genetics Program and the Genetics Institute at OHSU.Herbert A. Fritsche, Ph.D.
Dr. Fritsche is Professor of Laboratory Medicine and Chief of Clinical Chemistry at the University of Texas MD Anderson Cancer Center.Patrick R. Murray, Ph.D.
Dr. Murray is Chief, Microbiology Service, Department of Laboratory Medicine, National Institutes of Health Clinical Center*.Franklyn G. Prendergast, MD, Ph.D.
Dr. Prendergast is Edmond and Marion Guggenheim Professor of Biochemistry and Molecular Biology and Professor of Molecular Pharmacology and Experimental Therapeutics at the Mayo Clinic. He is also Director, Mayo Clinic Center for Individualized Medicine.David Relman, MD
Dr. Relman is Chief of Infectious Diseases at the Palo Alto Veteran’s Administration Hospital and Associate Professor of Medicine, Microbiology and Immunology at the Stanford University School of Medicine.Michael F. Sarosdy, MD
Dr. Sarosdy is a board-certified urologic surgeon at the Cancer Therapy and Research Center, San Antonio, TX and was previously Chief, Division of Urologic Surgery at UT San Antonio Health Science Center, and Director of the South Texas Prostate Cancer Program at the San Antonio Cancer Institute.* NO ENDORSEMENT OF ANY ORGANIZATION, PRODUCT OR SERVICE MENTIONED IN THIS PRESS RELEASE IS INTENDED BY THE NATIONAL INSTITUTES OF HEALTH OR ITS EMPLOYEES OR SHOULD BE INFERRED